Back
UBS Sets $1,250 Eli Lilly Target on Obesity Drug Outlook
Back
Stock News
Themes
UBS Sets $1,250 Eli Lilly Target on Obesity Drug Outlook
Donald Trump
UBS Sets $1,250 Eli Lilly Target on Obesity Drug Outlook
Edgen Stock
·
Jan 09 2026, 17:28
Share to
Share to
Copy link
LLY
+0.27%
source:
[1] Here’s What UBS Thinks About Eli Lilly and Company (LLY)
Recommend
Danaher's 26% Gain Masks Weakening Financials
Jan 20 2026, 15:51
Welltower Schedules Q4 2025 Earnings Release for February 10
Jan 20 2026, 15:49
Precious Metals ETFs Gain Over 100% as Silver Climbs 194%
Jan 20 2026, 15:48
Edgen Stock·Jan 09 2026, 17:28Edgen Stock·Jan 09 2026, 17:28
Edgen Stock·Jan 09 2026, 17:28